Big Pharma Split Corp. (XN4)
FSX
Closed
Aug 25, 2026
Day's Range
9.7552 wk Range
6.90Overview - XN4 - Big Pharma Split Corp.
Key Statistics
Valuation
Enterprise Value
14.65M
P/E (Trailing)
‪11.63‬
Price / Sales (TTM)
‪2.24‬
Price / Book
‪1.06‬
Profitability
Profit Margin
‪86.11%‬
Operating Margin
‪93.38%‬
Return on Assets
‪9.33%‬
Return on Equity
‪27.54%‬
Ownership
Shares Outstanding
1.30M
Price stats
Beta
‪0.72‬
50-Day Avg
‪8.74‬
200-Day Avg
‪8.55‬
Dividends
Frequency
Monthly
Peers - XN4 - Big Pharma Split Corp.
Peer Comparison
Compared with companies in Asset Management listed on FSX.
- XN4FSXBig Pharma Split Corp.11.19MMarket Cap+21.84%52-week change11.64P/E (Trailing)‪86.11%‬Profit Margin
- AMGFSXAmgen Inc.203.44BMarket Cap+33.57%52-week change27.32P/E (Trailing)‪22.95%‬Profit Margin
- BLQAFSXBlackRock, Inc.148.64BMarket Cap+2.17%52-week change23.20P/E (Trailing)‪46.73%‬Profit Margin
- BBN1FSXBlackstone Inc.146.06BMarket Cap-18.02%52-week change31.84P/E (Trailing)‪22.72%‬Profit Margin
- ASGFSXAssicurazioni Generali S.p.A.65.56BMarket Cap+21.53%52-week change14.57P/E (Trailing)‪7.68%‬Profit Margin
- CPAFSXColgate-Palmolive Company60.95BMarket Cap+6.86%52-week change34.60P/E (Trailing)‪9.68%‬Profit Margin
- FASFSXFastenal Co.49.92BMarket Cap+2.62%52-week change43.51P/E (Trailing)‪15.45%‬Profit Margin
Profile Summary - XN4 - Big Pharma Split Corp.
About
Big Pharma Split Corp. is a specialized investment corporation focused on providing investors with exposure to large pharmaceutical companies. Its primary function is to invest in a diversified portfolio of prominent pharmaceutical firms, offering both capital appreciation and dividend income. The corporation…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
